AliveCor QT Service vs vascuCAP
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
These tools are adjacent in their comparability, both leveraging AI for cardiovascular clinical decision support. AliveCor QT Service focuses on cardiac electrical activity by analyzing ECGs for QT interval measurements to inform medication safety, while vascuCAP (ElucidVivo/PlaqueIQ) analyzes CT angiograms to quantify plaque composition and assess cardiovascular risk. Therefore, AliveCor is suited for medication-related cardiac safety, whereas vascuCAP is designed for detailed vascular plaque assessment and stroke/heart attack risk stratification.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
AliveCor QT Service is a cloud-based Software as a Medical Device (SaMD) designed to provide instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs, primarily for assessing cardiac safety and informing medication prescribing decisions. vascuCAP (now ElucidVivo/PlaqueIQ) is an AI software for non-invasive CT angiography analysis, focusing on quantifying plaque composition and assessing cardiovascular risk to optimize treatment decisions for conditions like stroke and heart attack.
The AliveCor QT Service specifically analyzes ECGs obtained from AliveCor 6-Lead ambulatory ECG devices, such as the KardiaMobile 6L. In contrast, vascuCAP performs its analysis on non-invasive CT angiography (CTA) data.
AliveCor QT Service provides instant QT and QTc interval measurements, utilizing Bazett's and Fridericia's formulas, to enhance cardiac safety and inform medication adjustments. vascuCAP offers histologically-validated quantification and characterization of plaque components, including lipid-rich necrotic core, calcification, non-calcified matrix, and intraplaque hemorrhage, along with 3D visualization of arterial vessels and plaque for risk stratification.
AliveCor QT Service integrates with the KardiaStation app and KardiaPro portal, and provides an API for integration with EHR, SDK, CRM, EDC, and PSP platforms. vascuCAP supports DICOM integration and PACS/EMR interoperability to streamline its use within imaging and electronic health record systems.
Both AliveCor QT Service and vascuCAP are FDA-cleared, HIPAA compliant, and have a Business Associate Agreement (BAA). AliveCor QT Service is cleared as a cloud-based Software as a Medical Device (SaMD) for prescription use only by qualified healthcare professionals. vascuCAP is an FDA-cleared AI software for non-invasive CT angiography analysis.
More Comparisons
Backers
Who funded each tool's parent company.